Literature DB >> 22108199

EBV encoded miR-BHRF1-1 potentiates viral lytic replication by downregulating host p53 in nasopharyngeal carcinoma.

Zijian Li1, Xue Chen, Lili Li, Sufang Liu, Lifang Yang, Xiaoqian Ma, Min Tang, Ann M Bode, Zigang Dong, Lunquan Sun, Ya Cao.   

Abstract

miRNAs (microRNAs) are a class of non-coding small RNAs. The Epstein-Barr-virus (EBV) encoded miR-BHRF1-1 is barely expressed in most nasopharyngeal carcinoma (NPC) cells with EBV latent infection. Here, we used a strategy of overexpression and inhibition of miR-BHRF1-1 and showed that miR-BHRF1-1 is involved in TPA-induced accumulation of EBV lytic proteins and viral copies in late lytic cycle. The data further suggested that the miR-BHRF1-1-potentiated induction of EBV lytic replication was accompanied by inhibiting p53 expression. Our results demonstrated that the EBV original pathogen miR-BHRF1-1 is involved in the control of EBV late lytic replication by directly targeting the host p53 gene.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108199     DOI: 10.1016/j.biocel.2011.11.007

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  18 in total

Review 1.  Herpesvirus microRNAs for use in gene therapy immune-evasion strategies.

Authors:  S T F Bots; R C Hoeben
Journal:  Gene Ther       Date:  2017-05-09       Impact factor: 5.250

2.  MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Authors:  Yu-Jin Jung; Hoyun Choi; Hyoji Kim; Suk Kyeong Lee
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

3.  Lactic Acid Downregulates Viral MicroRNA To Promote Epstein-Barr Virus-Immortalized B Lymphoblastic Cell Adhesion and Growth.

Authors:  Xiaohui Mo; Fang Wei; Yin Tong; Ling Ding; Qing Zhu; Shujuan Du; Fei Tan; Caixia Zhu; Yuyan Wang; Qian Yu; Yeqiang Liu; Erle S Robertson; Zhenghong Yuan; Qiliang Cai
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

Review 4.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

Review 5.  Regulation of viral oncogenesis by microRNAs.

Authors:  Xiaojie Xu; Qinong Ye
Journal:  Mol Cell Oncol       Date:  2014-09-02

Review 6.  Metabolic Control by DNA Tumor Virus-Encoded Proteins.

Authors:  Martin A Prusinkiewicz; Joe S Mymryk
Journal:  Pathogens       Date:  2021-05-06

Review 7.  Emerging themes from EBV and KSHV microRNA targets.

Authors:  Dhivya Ramalingam; Philippe Kieffer-Kwon; Joseph M Ziegelbauer
Journal:  Viruses       Date:  2012-09-21       Impact factor: 5.048

8.  Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival.

Authors:  Alessandra Ferrajoli; Cristina Ivan; Maria Ciccone; Masayoshi Shimizu; Yoshiaki Kita; Masahisha Ohtsuka; Lucilla D'Abundo; Jun Qiang; Susan Lerner; Nazila Nouraee; Kari G Rabe; Laura Z Rassenti; Katrien Van Roosbroeck; John T Manning; Yuan Yuan; Xinna Zhang; Tait D Shanafelt; William G Wierda; Silvia Sabbioni; Jeffrey J Tarrand; Zeev Estrov; Milan Radovich; Han Liang; Massimo Negrini; Thomas J Kipps; Neil E Kay; Michael Keating; George A Calin
Journal:  EBioMedicine       Date:  2015-04-29       Impact factor: 8.143

Review 9.  Pathogens Use and Abuse MicroRNAs to Deceive the Immune System.

Authors:  Thomas B Flór; Bianca Blom
Journal:  Int J Mol Sci       Date:  2016-04-09       Impact factor: 5.923

10.  Integrated analysis of microRNA regulatory network in nasopharyngeal carcinoma with deep sequencing.

Authors:  Fan Wang; Juan Lu; Xiaohong Peng; Jie Wang; Xiong Liu; Xiaomei Chen; Yiqi Jiang; Xiangping Li; Bao Zhang
Journal:  J Exp Clin Cancer Res       Date:  2016-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.